Monday, October 27, 2014 9:38:44 AM
We are going to have funding updates shortly along with filing updates..
Therapy Cells (2000) Ltd Commercializing
USPatent #8,372,644
Time to expiry of this patent
21.2 Years
Therapy Cells announces a new license granted to Contravaccine Ltd. This license enables Contravaccine to grow a line of granulosa cells for use in NON-Surgical sterilisation of Cats and Dogs! This joint venture is in final clinical testing with access to the existing $650 Million/Annum North American spey market. Royalties to flow to Therapy Cells by December 2014.
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM